Employing the spontaneous metastasis mouse model bearing 4T1 mammary carcinoma cells with poor immunogenicity, in contrast to other monotherapy groups, the union of anti-CTLA-4 and local RT has statistical significance in the reduction of in situ tumor volume and lung metastases. This evidence concerns the gene CTLA4 and neoplasm.